Better Context → Better Decisions
Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers without corporate access will find a wealth of contextualized life science insight ready to be purchased in the FENIX Marketplace. If our content sharing limitations are inconvenient for you, reach out to Brady for unlimited corporate, institutional, or individual access.
$599
Posted in: Insulin Delivery, Topics Apr 13 | 2018Common Sensing and Haselmeier ThoughtsPurchase Blast
$599
Posted in: Glucose Monitoring, Topics Apr 11 | 2018Livongo partners with Cambia Health Solutions and raises $105MPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, GLP-1RA, Topics Apr 11 | 2018Mylan IR Day Highlights; Biosimilar Victoza and Toujeo in DevelopmentPurchase Blast
$599
Posted in: Glucagon, Topics Apr 11 | 2018Zealand and Roche Partner for Ph3 stable glucagon development in CHIPurchase Blast
$599
Posted in: Glucose Monitoring, Topics Apr 05 | 2018Ascensia Contour NEXT access expanded on UHCPurchase Blast
$599
Posted in: Other, Topics Apr 04 | 2018Lilly invests in beta cell encapsulation developmentPurchase Blast
$599
Posted in: Basal Insulin, GLP-1RA, Topics Apr 03 | 2018Bydureon Approved as Add-On to Basal InsulinPurchase Blast
$599
Posted in: Glucose Monitoring, Topics Mar 30 | 2018iCGM FDA “Special Controls” AnalysisPurchase Blast
$599
Posted in: Glucose Monitoring, Topics Mar 29 | 2018FENIX Analysis: Thoughts on Dexcom G6 ApprovalPurchase Blast
$599
Posted in: Glucose Monitoring, Topics Mar 27 | 2018FENIX Analysis: Senseonics FDA Adcom Briefing Documents; Dexcom G6 ApprovalPurchase Blast
$599
Posted in: Glucose Monitoring, Topics Mar 16 | 2018J&J receives offer for LifeScan BGM businessPurchase Blast
$599
Posted in: Bolus Insulin, Insulin Delivery, Topics Mar 14 | 2018New Lilly uRAI trials including H2H vs. FiaspPurchase Blast
$599
Posted in: Bolus Insulin, Glucose Monitoring, Insulin Delivery, SGLT2i, Topics Mar 09 | 2018JPM Day 2: Sanofi, Lilly, Lexicon, Dexcom and morePurchase Blast
$599
Posted in: Basal Insulin, Topics Feb 21 | 2018Biocon Malaysian facility receives six form 483 observations from FDAPurchase BlastGet the Latest Analysis
Stay informed and aligned with frequent updates to keep a pulse on the industry.
If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact Brady.
